AllianceBernstein
STOK icon

AllianceBernstein’s Stoke Therapeutics STOK Stock Holding History

AllianceBernstein’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Buy
41,830
+1,200
+3% +$39.4K ﹤0.01% 2215
2025
Q4 		$1.29M Hold
40,630
– – ﹤0.01% 2226
2025
Q3 		$955K Hold
40,630
– – ﹤0.01% 2372
2025
Q2 		$461K Hold
40,630
– – ﹤0.01% 2688
2025
Q1 		$270K Hold
40,630
– – ﹤0.01% 2826
2024
Q4 		$448K Hold
40,630
– – ﹤0.01% 2686
2024
Q3 		$499K Hold
40,630
– – ﹤0.01% 2665
2024
Q2 		$549K Buy
40,630
+3,290
+9% +$44.4K ﹤0.01% 2623
2024
Q1 		$504K Hold
37,340
– – ﹤0.01% 2585
2023
Q4 		$196K Sell
37,340
-3,980
-10% -$17K ﹤0.01% 2984
2023
Q3 		$163K Hold
41,320
– – ﹤0.01% 3002
2023
Q2 		$439K Buy
41,320
+6,520
+19% +$69.4K ﹤0.01% 2706
2023
Q1 		$290K Buy
34,800
+4,400
+14% +$39.7K ﹤0.01% 2787
2022
Q4 		$281K Buy
30,400
+2,900
+11% +$30.2K ﹤0.01% 2897
2022
Q3 		$353K Buy
27,500
+3,800
+16% +$60.6K ﹤0.01% 2797
2022
Q2 		$313K Buy
23,700
+3,900
+20% +$59.2K ﹤0.01% 2863
2022
Q1 		$417K Hold
19,800
– – ﹤0.01% 2753
2021
Q4 		$475K Buy
19,800
+1,200
+6% +$28.6K ﹤0.01% 2768
2021
Q3 		$473K Sell
18,600
-1,200
-6% -$33.5K ﹤0.01% 2776
2021
Q2 		$666K Buy
19,800
+1,700
+9% +$60.1K ﹤0.01% 2693
2021
Q1 		$703K Buy
18,100
+700
+4% +$39.9K ﹤0.01% 2542
2020
Q4 		$1.08M Sell
17,400
-3,300
-16% -$151K ﹤0.01% 2262
2020
Q3 		$693K Sell
20,700
-1,200
-5% -$34.3K ﹤0.01% 2352
2020
Q2 		$522K Buy
21,900
+4,600
+27% +$109K ﹤0.01% 2582
2020
Q1 		$396K Buy
+17,300
New +$427K ﹤0.01% 2471

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AllianceBernstein's STOK Position: Q1 2026 in Review

AllianceBernstein increased its Stoke Therapeutics (STOK) stake by 3% in Q1 2026, buying an estimated $39.4K and bringing the position to 41,830 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2215.

AllianceBernstein first reported a position in STOK in Q1 2020 and has held it in 25 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • AllianceBernstein held 41,830 shares of Stoke Therapeutics worth $1.33M as of Q1 2026.
  • AllianceBernstein bought 1,200 Stoke Therapeutics shares in Q1 2026, an estimated $39.4K.
  • Stoke Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2215 holding.
  • AllianceBernstein first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.